Calpain as a multi-site regulator of cell cycle

Biochemical Pharmacology

Volumn 67, Issue 8, 2004, Pages 1513-1521

  Jánossy, Judit ^a   Ubezio, Paolo ^b   Apáti, Ágota ^c   Magócsi, Mária ^c   Tompa, Peter ^a   Friedrich, Peter ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c NATIONAL MEDICAL CENTER   (Hungary)

Author keywords

BrdU; Bromodeoxyuridine; Cdk; Cyclin dependent kinase; Dimethyl sulfoxide; DMSO; FACS; Fluorescence activated cell sorting; GM CSF; Granulocyte macrophage colony stimulating factor; NGS; Normal goat serum; PBS; PCNA; Phosphate buffered saline

Indexed keywords

BROXURIDINE; CALPAIN; CALPASTATIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PD 150606; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ALGORITHM; ANALYTIC METHOD; ARTICLE; CELL COUNT; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL LABELING; CELL STIMULATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; DRUG SCREENING; DRUG SPECIFICITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INHIBITION KINETICS; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TIME;

CALPAIN; CELL CYCLE; CELL DIVISION; CELL SURVIVAL; FLOW CYTOMETRY; G1 PHASE; G2 PHASE; GLYCOPROTEINS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MITOSIS; S PHASE; TUMOR CELLS, CULTURED;

EID: 1642339463     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2003.12.021     Document Type: Article

References (38)

1. Sorimachi H., Ishiura S., Suzuki K. Structure and physiological function of calpains. Biochem. J. 328:1997;721-732.
2. Sorimachi H., Suzuki K. The structure of calpain. J. Biochem. (Tokyo). 129:2001;653-664.
3. Margis R., Margis-Pinheiro M. Phytocalpains: orthologous calcium-dependent cysteine proteinases. Trends Plant Sci. 8:2003;58-62.
4. Arthur J.S., Elce J.S., Hegadorn C., Williams K., Greer P.A. Disruption of the murine calpain small subunit gene, Capn4: calpain is essential for embryonic development but not for cell growth and division. Mol. Cell Biol. 20:2000;4474-4481.
5. Glading A., Lauffenburger D.A., Wells A. Cutting to the chase: calpain proteases in cell motility. Trends Cell Biol. 12:2002;46-54.
6. Wang K.K., Yuen P.W. Development and therapeutic potential of calpain inhibitors. Adv. Pharmacol. 37:1997;117-152.
7. Mellgren R.L. Specificities of cell permeant peptidyl inhibitors for the proteinase activities of mu-calpain and the 20 S proteasome. J. Biol. Chem. 272:1997;29899-29903.
8. Schollmeyer J.E. Calpain II involvement in mitosis. Science. 240:1988;911-913.
9. Watanabe N., Vande Woude G.F., Ikawa Y., Sagata N. Specific proteolysis of the c-mos proto-oncogene product by calpain on fertilization of Xenopus eggs. Nature. 342:1989;505-511.
10. Mellgren R.L. Evidence for participation of a calpain-like cysteine protease in cell cycle progression through late G1 phase. Biochem. Biophys. Res. Commun. 236:1997;555-558.
11. Zhang W., Lu Q., Xie Z.J., Mellgren R.L. Inhibition of the growth of WI-38 fibroblasts by benzyloxycarbonyl-Leu-Leu-Tyr diazomethyl ketone: evidence that cleavage of p53 by a calpain-like protease is necessary for G1 to S-phase transition. Oncogene. 14:1997;255-263.
12. March K.L., Wilensky R.L., Roeske R.W., Hathaway D.R. Effects of thiol protease inhibitors on cell cycle and proliferation of vascular smooth muscle cells in culture. Circ. Res. 72:1993;413-423.
13. Dietrich C., Bartsch T., Schanz F., Oesch F., Wieser R.J. p53-dependent cell cycle arrest induced by N-acetyl-L-leucinyl-L-leucinyl-L-norleucinal in platelet-derived growth factor-stimulated human fibroblasts. Proc. Natl. Acad. Sci. U.S.A. 93:1996;10815-10819.
14. Kubbutat M.H., Vousden K.H. Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability. Mol. Cell Biol. 17:1997;460-468.
15. Patel Y.M., Lane M.D. Mitotic clonal expansion during preadipocyte differentiation: calpain-mediated turnover of p27. J. Biol. Chem. 275:2000;17653-17660.
16. Choi Y.H., Lee S.J., Nguyen P., Jang J.S., Lee J., Wu M.L., Takano E., Maki M., Henkart P.A., Trepel J.B. Regulation of cyclin D1 by calpain protease. J. Biol. Chem. 272:1997;28479-28484.
17. Pariat M., Carillo S., Molinari M., Salvat C., Debussche L., Bracco L., Milner J., Piechaczyk M. Proteolysis by calpains: a possible contribution to degradation of p53. Mol. Cell Biol. 17:1997;2806-2815.
18. Xu Y., Mellgren R.L. Calpain inhibition decreases the growth rate of mammalian cell colonies. J. Biol. Chem. 277:2002;21474-21479.
19. Benetti R., Del Sal G., Monte M., Paroni G., Brancolini C., Schneider C. The death substrate Gas2 binds m-calpain and increases susceptibility to p53-dependent apoptosis. EMBO J. 20:2001;2702-2714.
20. Jang J.S., Lee S.J., Choi Y.H., Nguyen P.M., Lee J., Hwang S.G., Wu M.L., Takano E., Maki M., Henkart P.A., Trepel J.B. Posttranslational regulation of the retinoblastoma gene family member p107 by calpain protease. Oncogene. 18:1999;1789-1796.
21. Wang K.K., Nath R., Posner A., Raser K.J., Buroker-Kilgore M., Hajimohammadreza I., Probert A.W. Jr., Marcoux F.W., Ye Q., Takano E., Hatanaka M., Maki M., Caner H., Collins J.L., Fergus A., Lee K.S., Lunney E.A., Hays S.J., Yuen P. An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective. Proc. Natl Acad. Sci. U.S.A. 93:1996;6687-6692.
22. Liu X., Rainey J.J., Harriman J.F., Schnellmann R.G. Calpains mediate acute renal cell death: role of autolysis and translocation. Am. J. Physiol. Renal Physiol. 281:2001;F728-F738.
23. Potter D.A., Srirangam A., Fiacco K.A., Brocks D., Hawes J., Herndon C., Maki M., Acheson D., Herman I.M. Calpain regulates enterocyte brush border actin assembly and pathogenic Escherichia coli-mediated effacement. J. Biol. Chem. 278:2003;30403-30412.
24. Pollack J.R., Witt R.C., Sugimoto J.T. Differential effects of calpain inhibitors on hypertrophy of cardiomyocytes. Mol. Cell Biochem. 251:2003;47-50.
25. Van den Bosch L., Van Damme P., Vleminckx V., Van Houtte E., Lemmens G., Missiaen L., Callewaert G., Robberecht W. An alpha-mercaptoacrylic acid derivative (PD 150606) inhibits selective motor neuron death via inhibition of kainate-induced Ca2+ influx and not via calpain inhibition. Neuropharmacology. 42:2002;706-713.
26. Heinrich M.C., Griffith D.J., Druker B.J., Wait C.L., Ott K.A., Zigler A.J. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor. Blood. 96:2000;925-932.
27. Gabrilove J.L. Angiogenic growth factors: autocrine and paracrine regulation of survival in hematologic malignancies. Oncologist. 6(Suppl. 5):2001;4-7.
28. Kitamura T., Tange T., Terasawa T., Chiba S., Kuwaki T., Miyagawa K., Piao Y.F., Miyazono K., Urabe A., Takaku F. Establishment and characterization of a unique human cell line that proliferates dependently on GM-CSF, IL-3, or erythropoietin. J. Cell Physiol. 140:1989;323-334.
29. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
30. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. U.S.A. 76:1979;4350-4354.
31. Darzynkiewicz Z., Juan G., Li X., Gorczyca W., Murakami T., Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry. 27:1997;1-20.
32. Apati A., Janossy J., Brozik A., Bauer P.I., Magocsi M. Calcium induces cell survival and proliferation through the activation of the MAPK pathway in a human hormone-dependent leukemia cell line, TF-1. J. Biol. Chem. 278:2003;9235-9243.
33. Liu W., Linn S. Proteolysis of the human DNA polymerase epsilon catalytic sububnit by caspase-3 and calpain specifically during apoptosis. Nucleic Acid Res. 28:2000;4180-4188.
34. Navas T.A., Zhou Z., Elledge S.J. DNA polymerase epsilon links the DNA replication machinery to the S phase checkpoint. Cell. 80:1995;29-39.
35. Duesbery N.S., Vande Woude G.F. Developmental biology: an arresting activity. Nature. 416:2002;804-805.
36. Cross S.M., Sanchez C.A., Morgan C.A., Schimke M.K., Ramel S., Idzerda R.L., Rasking W.H., Reid B.J. A p53-dependent mouse spindle checkpoint. Science. 267:1995;1353-1356.
37. Ando T., Kawabe T., Ohara H., Ducommun B., Itoh M., Okamoto T. Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage. J. Biol. Chem. 276:2001;42971-42977.
38. Kawabe T., Suganuma M., Ando T., Kimura M., Hori H., Okamoto T. Cdc25C interacts with PCNA at G2/M transition. Oncogene. 21:2002;1717-1726.